Chevallier, P <br/><br/>
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).  [electronic resource] 

 -  Bone marrow transplantation  Mar 2014 
 - 361-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2013.186  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>France<br/>HLA Antigens--chemistry<br/>Hematologic Neoplasms--mortality<br/>Hodgkin Disease--mortality<br/>Humans<br/>Lymphoma, Non-Hodgkin--mortality<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--mortality<br/>Myeloproliferative Disorders--mortality<br/>Proportional Hazards Models<br/>Recurrence<br/>Retrospective Studies<br/>Societies, Medical<br/>Stem Cell Transplantation<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult